BioNTech SE (BNTX)
90.50
-5.34
(-5.57%)
USD |
NASDAQ |
Oct 13, 13:16
BioNTech Total Return Level : 97.13 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 97.13 |
| October 09, 2026 | 98.27 |
| October 08, 2026 | 93.30 |
| October 07, 2026 | 96.53 |
| October 06, 2026 | 97.02 |
| October 05, 2026 | 98.95 |
| October 02, 2026 | 98.20 |
| October 01, 2026 | 98.15 |
| September 30, 2026 | 99.62 |
| September 29, 2026 | 99.90 |
| September 28, 2026 | 100.41 |
| September 25, 2026 | 99.85 |
| September 24, 2026 | 100.60 |
| September 23, 2026 | 99.79 |
| September 22, 2026 | 102.23 |
| September 21, 2026 | 99.32 |
| September 18, 2026 | 97.35 |
| September 17, 2026 | 99.99 |
| September 16, 2026 | 97.12 |
| September 15, 2026 | 97.99 |
| September 14, 2026 | 100.19 |
| September 11, 2026 | 98.03 |
| September 10, 2026 | 97.70 |
| September 09, 2026 | 99.45 |
| September 08, 2026 | 99.99 |
| Date | Value |
|---|---|
| September 04, 2026 | 105.16 |
| September 03, 2026 | 104.27 |
| September 02, 2026 | 105.21 |
| September 01, 2026 | 103.32 |
| August 31, 2026 | 102.98 |
| August 28, 2026 | 103.45 |
| August 27, 2026 | 112.90 |
| August 26, 2026 | 114.08 |
| August 25, 2026 | 115.59 |
| August 24, 2026 | 114.34 |
| August 21, 2026 | 118.14 |
| August 20, 2026 | 112.38 |
| August 19, 2026 | 114.64 |
| August 18, 2026 | 94.00 |
| August 17, 2026 | 92.83 |
| August 14, 2026 | 94.34 |
| August 13, 2026 | 93.36 |
| August 12, 2026 | 93.99 |
| August 11, 2026 | 94.05 |
| August 10, 2026 | 94.05 |
| August 07, 2026 | 94.93 |
| August 06, 2026 | 92.42 |
| August 05, 2026 | 93.42 |
| August 04, 2026 | 92.58 |
| August 03, 2026 | 93.49 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Biodexa Pharmaceuticals Plc | 0.3832 |
| Moderna, Inc. | 213.74 |
| Mereo BioPharma Group Plc | 0.3152 |
| NuCana Plc | 1.08 |
| Immatics NV | 7.21 |